We use cookies to deliver our online services. Details of the cookies we use and instructions on how to disable them are set out in our Cookies Policy. By using this website you agree to our use of cookies. To close this message click close.

Supreme Court May Decide Whether “Reverse Payment” Settlements Violate Antitrust Law

15 August 2012


Patent litigation in the pharmaceutical industry impacts billions of dollars in pharmaceutical sales annually. Cases often involve a brand name drug manufacturer seeking to stop a competitor from selling a generic version of the brand name’s drug. In some cases, the parties reach a settlement that includes a delay in the generic entry date and some monetary consideration from the brand name manufacturer.

Read More: Supreme Court May Decide Whether "Reverse Payment" Settlements Violate Antitrust Law


Loading data